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Background: Patients with periodontitis seek periodontal-orthodontic treatment to address certain functional and
aesthetic problems. However, little is known of the effect of periodontitis on orthodontic treatment. Thus, we
compared the differences in peptide mass fingerprints of orthodontic patients with and without periodontitis by
MALDI-TOF MS using a magnetic bead-based peptidome analysis of saliva samples. In this way, we aimed to
identify and explore a panel of differentially-expressed specific peptides.
Results: Saliva samples from 24 patients (eight orthodontic patients without periodontitis, eight with periodontitis
and another eight with periodontitis but no orthodontic treatment) were analyzed, and peptide mass fingerprints
were created by scanning MS signals using matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS) combined with magnetic beads. Nine mass peaks showed significant differences.
Orthodontic patients in the group without periodontal disease showed higher mass peaks for seven peptides of
the nine, whereas the mass peaks for the other two peptides were higher in the periodontal-orthodontic patients.
Besides, these differentially-expressed peptides were sequenced.
Conclusions: The elucidated candidate biomarkers indicated interactions between periodontal condition and
orthodontic treatment and their contributions to the changes of saliva protein profiles. Our results provide novel
insight into the altered salivary protein profile during periodontal-orthodontic treatment, and may lead to the
development of a therapeutic monitoring strategy for periodontics and orthodontics.
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Periodontal-orthodontic treatment is usually needed to
correct malocclusions, and may also improve periodontal
health [1]. Patients who have chronic periodontal pro-
blems want to improve not only their malocclusions to
obtain a perfect facial and tooth profile with orthodontic
treatment, but also their periodontal condition. However,
some doctors believe that orthodontic treatment aggra-
vates periodontal damage [2]; the matter remains disputed.
The difference in osteogenesis between periodontitis and
non-periodontitis patients [3] may lead to differences in* Correspondence: moleculecf@gmail.com; jxlin@pku.edu.cn
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reproduction in any medium, provided the orthe effect of orthodontic treatment [4]. The aim of this
study was to determine the differences between periodon-
tal and non-periodontal orthodontic patients.
Bacterial plaque is an etiologic factor in periodontitis
[5]. The pathogenesis of this disease in adults results in
a loss of connective tissue, bone support, and, ultimately,
teeth [6]. The diagnosis of periodontitis and identi-
fication of at-risk patients are challenging. Periodontal
condition is usually determined visually by clinical peri-
odontal and X-ray examinations, which are subject to
considerable measurement error due to clinical experi-
ence, and are often poorly tolerated by patients.
Saliva is a complex hypotonic hydrated solution [7]
that contains 3397 different proteins with a variety of
biological functions [8]. Whole saliva comprises the
secretions of the major and minor saliva glands, non-
salivary gingival crevicular fluid, bronchial secretions,
bacteria and bacterial products, deciduous epithelialLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Complete mass spectra graph. Complete mass spectra in the range 1000–9000 Da, showing the peptide fingerprints of a saliva
sample from a single patient in each group: orthodontic patients without periodontitis (A); orthodontic patients with periodontitis (B). m/z,
mass-to-charge ratio.
Table 1 Significant (p <0.05) m/z values discriminating
samples from the two groups










*Tendency, m/z value intensity trend between the two groups: ↑, higher
intensity in group B than A; ↓, lower intensity in group B than A. m/z, mass-to-
charge ratio. A, the orthodontic patients without periodontitis; B, the
orthodontic patients with periodontitis.
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http://www.proteomesci.com/content/10/1/63cells, and food debris. Moreover, saliva contains mole-
cules which could be diffused or filtrated from blood [9].
For example, human C-reactive protein (CRP), which is
used to assess the coronary events, could be present in
saliva [10]. Periodontitis can involve the modified pro-
duction or release of various factors, such as hormones
and cytokines. We sought to discover a candidate bio-
marker that can facilitate the detection of periodontal
changes before pathological symptoms occur.
Since saliva contains multiple potentially informative
components and its collection is non-invasive, low-cost,
and simple, research is increasingly focusing on the ana-
lysis of oral and systemic conditions using saliva as a de-
tection strategy [11,12]. Moreover, there are databases
(http://bioinformatics.ua.pt/OralCard/ and http://www.
hspp.ucla.edu/) that compile proteomics data from oral
cavity, contributing to the salivary analysis. And protein
profiling methods such as two-dimensional polyacryl-
amide gel electrophoresis for separation and MS for
identification have been used to investigate various
conditions and disorders, including breast cancer [13],
Sjögren’s syndrome [14], rheumatoid arthritis [15], and
oral pathologies such as oral cancer [16,17], dental car-
ies [18], cleft palate [19], and periodontitis [20].
We used matrix-assisted laser desorption/ionization
time-of-flight mass spectrometry (MALDI-TOF MS), a
sensitive MS-based proteomic technique, to detect pep-
tides over a large mass range. The mass spectra gener-
ated by this technique are easy to interpret [21]. Here,
MALDI-TOF MS was used in combination with WCX
to select peptides in the range of 1000–10000 Da prior
to further identification. The effectiveness of this com-
bination of techniques has been confirmed in many
serum-based peptide profile identification studies
[22,23]. MALDI-TOF MS generated accurate salivary
protein profiles of patients with fixed orthodontic appli-
ances with and without periodontitis.In this study, the peptide mass profiles of saliva sam-
ples were investigated using magnetic bead-based pepti-
dome analysis. In this way, we aimed to identify a panel
of differentially-expressed specific candidate biomarkers.
Results
To investigate the differences between periodontal-
orthodontic and non-periodontal orthodontic patients,
the entire mass spectra of the extracted peptide samples
from 24 subjects (eight per group) were obtained by
MALDI-TOF MS (Figure 1). Saliva peptidome finger-
print peaks were characterized in each patient by show-
ing the maximum intensity within a particular m/z
range. The molecular weight of the majority of the pep-
tides was 1000–7000 Da. The mass spectra peaks were
then quantified and compared.
An average of 109 protein mass peaks was found. The
peak intensities of nine (1062.1, 1454.2, 2213.2, 2621.9,
3016.1, 3154.4, 3163.4, 5378.5, and 5435.2 Da) differed
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Orthodontic patients in the group without periodontal
disease showed higher mass peaks for peptides of
2213.2, 2621.9, 3016.1, 3154.4, 3163.4, 5378.5, and
5435.2 Da, whereas the mass peaks for the peptides of
1062.1 and 1454.2 Da were higher in the periodontal-
orthodontic patients (Figures 2 and 3).
The most significant differences were exhibited by the
3163.4- and 1454.2-Da proteins (p <0.01); the fit of theFigure 2 Column view of the mass spectra of the three groups. The p
expression of nine salivary peptides. Noticeably, significant differences were
**p <0.01).other combinations was not as good. Thus, we chose
these two peptides to establish a fitted curve between
the two groups (Figure 4). Samples from the two groups
were well-separated, indicating that the fitting results
were satisfactory.
Moreover, using LTQ-Orbitrap-MS detection, eight
(1062.1, 1454.2, 2213.2, 2621.9, 3016.1, 3154.4, 3163.4,
5378.5, and 5435.2 Da) of the nine differentially-
expressed peptides were successfully identified (Table 2).eak intensities of the three different groups showed differential
investigated between the two orthodontic groups. (*p <0.05;
Figure 3 Three-dimensional m/z ratio-intensity maps showing
significantly different proteins. Peptides of 1454.2-Da and
3163.4-Da were the two that were most significantly different.
Green curve, non-periodontal orthodontic group; red curve,
periodontal-orthodontic group.
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Adult patients with periodontal disease exhibit tooth
malocclusions such as flaring of the anterior segment.
This unaesthetic appearance and/or dysfunction are the
primary reasons for undergoing periodontal-orthodontic
treatment using a multidisciplinary approach [24]. Com-
bined orthodontic and periodontal treatment does not
compromise the therapeutic effectiveness of the latter
[25]. Indeed, this combination may be beneficial since it
leads to increased bone resorption stability, a lack of in-
cisor flaring, and improvements in bone defects [26].
However, some authors argue that orthodontic treat-
ment is unsuitable in chronic periodontal patients be-
cause bacterial plaque is an etiologic factor in the
development of periodontitis and the presence of ortho-
dontic appliances facilitates plaque growth and matur-
ation. Thus, the periodontal condition could worsen
after orthodontic treatment [27]. Therefore, we exam-
ined periodontal-orthodontic patients with a view to
elucidating the differences between them and non-
periodontal orthodontic patients.Figure 4 Scatter plots of the two groups generated by
combining the 3163.4-Da and 1454.2-Da proteins. The scatter
plots showed a well-fitting curve.Such differences could be caused by inflammatory fac-
tors related to periodontitis or other protein factors [28],
which may represent candidate biomarkers. A candidate
biomarker is defined as an informative signal associated
with a specific condition. The specificity and sensitivity
of a biomarker describe its usefulness in diagnosing a
specific condition or predicting its progress [29]. An ef-
fective biomarker should be measurable in an accessible
body fluid, such as serum, urine, or saliva [30]. Saliva
contains abundant proteins, peptides, and other small
molecules [8]. Thus, the salivary peptide spectrum may
be applied widely in the diagnosis and monitoring of oral
diseases. Progress has been made in screening for not
only oral diseases such as oral cancer [17], but also sys-
tematic conditions such as gastric cancer [31] and breast
cancer [13]. Studies of periodontitis using proteomics
[32,33] have been performed, and the demand for
periodontal-orthodontic combination treatment is in-
creasing. However, little research on the salivary peptide
spectrum in the periodontal-orthodontic area has been
conducted.
In the present study, we used MALDI-TOF MS-based
proteomic methods and WCX magnetic beads to exam-
ine all 24 saliva samples. Nine peaks that differed signi-
ficantly were found (Figure 2), of which two (3163.4
and 1454.2 Da) exhibited the most significant differences
(p <0.01). Orthodontic treatment is a prolonged proced-
ure. And in our previous study, alterations were found
in salivary proteins due to different orthodontic treat-
ment durations [34]. In this study, the peak intensities of
the three different groups showed differential expression
of salivary peptides, indicating the orthodontic treatment
could contribute to the change of salivary peptidome.
Noticeably, significant differences were investigated be-
tween the two orthodontic groups. This suggested that
differential expression of salivary peptidome profile did
exist between orthodontic patients with and without
periodontitis. Thus, this method provides a new tool for
analyzing the effect of periodontitis on orthodontic
treatment.
The peptide sequence identifications made in this
study have led to interesting speculations. The 3163.4-
Da peptide was identified as F2 prothrombin precursor.
Thrombin is a ‘trypsin-like’ serine protease protein
encoded by the F2 gene. Beyond its key role in the dy-
namic process of thrombus formation, thrombin has the
potential to exert actions such as inflammation and
leukocyte recruitment [35]. Moreover, isoform 1 of fi-
brinogen alpha chain precursor (FGA), which was the
predicted identity of the 3154.4- and 2621.9-Da peptides,
is encoded by FGA. It is cleaved by thrombin to form fi-
brin, indicating that it interacts with thrombin. Some
studies [36] suggested epithelial thrombomodulin (TM),
which binds to thrombin and converts it from a
Table 2 Sequences of the differentially-expressed peptides
Mean m/z value Peptide name Peptide sequence
3163.4 F2 Prothrombin precursor LRPLFEKKSLEDKTERELLESYIDGR
1454.2 SERPINA1(PRO2275) PLFMGKVVNPTQK
3154.4 FGA Isoform 1 of fibrinogen alpha chain precursor LIGQIVSSITASLR
2621.9 FGA Isoform 1 of fibrinogen alpha chain precursor SYKM*ADEAGSEADHEGTHSTKRGHAKSRP
5378.5 VWCE Isoform 1 of von Willebrand factor C and
EGF domain-containing protein precursor
APVNCSSCPGPPTASPSRPVLHLLQLLLRTNLM*KTQTLPTSPAGAHGPHSLA
1062.1 ITIH4 Isoform 2 of inter-alpha-trypsin inhibitor heavy
chain H4 precursor
SEMVVAGKLQ
3016.1 280-kDa protein LGVSPPPGAVLVLHSLPLEFPLAM*AFAEQ
5435.2 Unknown peptide-identification failure
2213.2 ACTB Actin, cytoplasmic 1 DLYANTVLSGGTTMYPGIADR
m/z, mass-to-charge ratio.
The English in this document has been checked by at least two professional editors, both native speakers of English. For a certificate, please see:
http://www.textcheck.com/certificate/OlkIGD.
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increased in gingival crevicular fluid of individuals with
chronic periodontitis. Moreover, gingipains, the major
periodontopathic bacterium Porphyromonas gingivalis-
derived cysteine proteases, lead to the degradation of
endothelial TM. In addition, reduced expression of TM
was found in gingival microvascular endothelia in
patients with periodontitis [37], and this may be involved
in the pathogenesis of periodontitis. Thus, these differ-
ential expression patterns of altered proteins may have
originated from periodontitis-associated inflammation or
differences in bone metabolism between orthodontic
patients with and without periodontitis. Ultimately, our
aim is to determine the protein or gene from which a
peptide is derived; however, this is complex. When the
distribution of the peptides with low molecular weight
were intended to match to the mass spectrometry spec-
tra relative peak area, it should be noted that these pep-
tides had complicated origins. Peptides in saliva could be
secreted peptides and proteolytic fragments of related
proteins [38]. Moreover, these components are subject
to secondary modifications from distinctive protein fam-
ilies. Thus, a peptide sequence usually does not exclu-
sively define a single protein.
As these specific peptides were investigated using this
relatively new combined method with no validation
using other techniques, thus, a larger sample size and
repeated trial or trial using other techniques are needed
to confirm the significant differences in peptide mass
peaks found in this study and its reproducibility. The es-
tablishment of a relatively complete protein-peptide
spectrum database will facilitate the determination of
both the source of the salivary protein profile variation
and the mechanism thereof. Moreover, the analysis of
saliva is inherently challenging because of the wide pro-
tein concentration range therein [29] and the presenceof multiple post-translational modifications [39]. Further
research into the composition of saliva will likely provide
novel tools for investigations of physiological and patho-
physiological states.
Conclusions
In conclusion, our data suggest that the salivary protein
profiles of periodontal, non-periodontal orthodontic
patients and periodontitis patients exhibit differential
mass spectra peak intensities (i.e., the peptide profile is
altered in cases of periodontitis). This represents a new
method of analyzing the effect of periodontitis on ortho-
dontics and orthodontic contribution to the alterations
of salivary peptidome profile, ultimately leading to
increased treatment efficacy. However, expansion of the
orthodontic patient dataset and the identification of add-
itional candidate biomarkers are necessary to establish




This study was approved by the Peking University Bio-
medical Ethics Committee. Adult subjects and parents
of pediatric subjects signed an informed consent form
before participating in the study.
Subjects
Patients seeking treatment at the Stomatology School of
Peking University were recruited in November, 2011. All
24 study subjects were generally ensured systemically
healthy via testing of serum basic biochemical items and
inquiring medical history, and those who presented with
caries, diseases of the oral mucosa, or oral cancers were
excluded. Recorded clinical periodontal parameters of
the subjects included bleeding on probing (BOP),probing
Zhang et al. Proteome Science 2012, 10:63 Page 6 of 8
http://www.proteomesci.com/content/10/1/63pocket depth (PPD) and clinical attachment level
(CAL). Chronic periodontitis was diagnosed in patients
who had six sites BOP on different teeth with
PPD≥6 mm and CAL>5 mm. Control orthodontic
patients had <10% of sites BOP and PPD<3 mm. And all
the periodontitis patients manifested to be moderate de-
gree of chronic periodontitis. Then the patients were
divided into three groups according; that is, periodontal-
orthodontic, non-periodontal orthodontic groups and
patients with periodontitis but no orthodontic treatment.
The characteristics of the subjects are presented in
Table 3.
The treatment procedure for all subjects involved the
use of a fixed appliance, followed by alignment, leveling,
and refinement procedures. All patients were asked to
maintain good oral hygiene during treatment and were
counseled regarding oral hygiene and tooth brushing
both before treatment and at each visit.
Saliva collection and processing
All individuals were asked to rest for 15 min before sal-
iva collection at 8:30 am, and not to eat or drink after
dinner the previous evening or to brush their teeth on
the collection day morning. The subjects sat upright in a
quiet room and were required to put the tip of their
tongue against the sublingual caruncle without straining.
Thus, the saliva, which was received in a paper cup for
the first 5 min, could run from the mouth, and we col-
lected 6 mL of the spontaneous saliva flow in a 50-mL
centrifuge tube. During the collection procedure,
patients were asked not to speak. Immediately after col-
lection, the unstimulated whole saliva samples were kept
on ice and then centrifuged at 9000 × g for 7 min at
4°C to remove insoluble materials, cells, and debris.
Ethylene diamine tetraacetic acid (1 mM; Sigma, St.
Louis, MO, USA) and 1 mM phenylmethyl sulfonylfluor-
ide (Sigma) were added to the sample supernatants to in-
hibit protease activity. Protein concentrations were
determined using the Lowry assay and ELx808 Protein
Assay (BioTek, Hercules, CA, USA). The supernatants
were kept at −80°C for further analysis.
Reagents and instruments
The WCX magnetic bead kit (SPE-C; Bioyong Tech,
Beijing, China), alpha-cyano-4-hydroxycinnamic acid
(HCCA), MALDI-TOF MS (Bruker Bio-sciences, Bremen,Table 3 Demographic information for the two groups
Group Sample size Age
Mean SD
orthodontic patients without periodontitis 8 35.4 1.3165
orthodontic patients with periodontitis 8 33 2.2509
patients with periodontitis 8 34.55 2.2181Germany), 100% ethanol (chromatographic grade), and
100% acetone (chromatographic grade) were freshly
prepared.
WCX fractionation and MALDI-TOF MS
The low-molecular-weight (LMW) salivary peptidome
contains enormous and important biological information
and they should be a rich source of specific candidate
biomarkers [13]. Unlike 2D-PAGE analysis, which only
allows the separation of proteins with molecular weight
in a range of 20–300 kDa, the magnetic bead-based
profiling MS technologies could cover a range of
1–250 kDa [29]. Moreover, the high-throughput nature
of MALDI-TOF MS makes fast screening for novel
candidate biomarkers possible, and this method is cost
effective and can be easily adopted [31]. Besides, this
combined method only required 20ul processed sample
for generating enough proteins peaks profiling by
MALDI-TOF-MS.
The WCX magnetic bead kit suspension was mixed by
shaking. After eluting and beating, the magnetic beads
were separated from the protein and the eluted peptide
samples were transferred to a clean 0.5-mL sample tube
for further analysis by MS.
Five microliters of HCCA substrate solution (0.4 g/L,
dissolved in acetone and ethanol) and 0.8-1.2 μL of elu-
ate were mixed. Next, 0.8-1.2 μL of this mixture was ap-
plied to a metal target plate and dried at room
temperature. Finally, the prepared samples were ana-
lyzed by MALDI-TOF MS. Peptides with a molecular
weight in the range of 1000–10000 Da were collected,
and 400 shots of laser energy were used. Peptide mass
fingerprints were obtained by accumulating 50 single
MS signal scans.
Identification of differentially expressed
candidate biomarkers
The sequences of peptides expressed differentially be-
tween the two groups were determined by nano-liquid
chromatography-electrospray ionization-tandem mass
spectrometry (nano-LC/ESI-MS/MS) using a setup con-
sisting of an Aquity UPLC system (Waters) and an LTQ
Obitrap XL mass spectrometer (Thermo Fisher)
equipped with a nano-ESI source. The obtained chroma-
tograms were analyzed with BioworksBrowser 3.3.1 SP1,
and the resulting mass lists were used in a database
search with Sequest™ [IPI Human (3.45)]. The para-
meters used to generate the peak list were: parent ion
and fragment mass relative accuracy (50 μg/g and 1 Da,
respectively).
Statistical analysis
A two-tailed t-test and Student’s t-test were used to com-
pare peptide peak intensities between the two groups.
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age (BioyongTech). A p-value <0.05 was considered
significant.
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